Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Broome

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA|February 8, 1985
'Break dancers' bursitis'H E Broome, R B Heppenstall
Gene|July 16, 1990
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyteD E Sabath, H E Broome, M B Prystowsky
American Journal of Hematology|January 1, 1995
Copper deficiency-induced anemia and neutropenia secondary to intestinal malabsorptionB A Hayton, H E Broome, R C Lilenbaum
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
TCR triggering of anergic CD4 T cells in murine AIDS induces apoptosis rather than cytokine synthesis and proliferationG Muralidhar, S Koch, H E Broome, et al.
Cell Death and Differentiation|April 14, 1999
Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, Bcl-2 or Bcl-x transductionH E Broome, C M Dargan, T Brunner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1995
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawalH E Broome, C M Dargan, S Krajewski, et al.
Molecular and Cellular Biology|August 1, 1987
Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytesH E Broome, J C Reed, E P Godillot, et al.
The Journal of Experimental Medicine|September 1, 1995
Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansionX Zhang, L Giangreco, H E Broome, et al.
Immunology|March 1, 1995
Apoptosis and Bcl-2 expression in cultured murine splenic T cellsH E Broome, C M Dargan, E F Bessent, et al.
Bone Marrow Transplantation|September 4, 2003
FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasiaM L Tanner, C K Hoh, A Bashey, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA|February 8, 1985
'Break dancers' bursitis'H E Broome, R B Heppenstall
Gene|July 16, 1990
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyteD E Sabath, H E Broome, M B Prystowsky
American Journal of Hematology|January 1, 1995
Copper deficiency-induced anemia and neutropenia secondary to intestinal malabsorptionB A Hayton, H E Broome, R C Lilenbaum
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
TCR triggering of anergic CD4 T cells in murine AIDS induces apoptosis rather than cytokine synthesis and proliferationG Muralidhar, S Koch, H E Broome, et al.
Cell Death and Differentiation|April 14, 1999
Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, Bcl-2 or Bcl-x transductionH E Broome, C M Dargan, T Brunner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1995
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawalH E Broome, C M Dargan, S Krajewski, et al.
Molecular and Cellular Biology|August 1, 1987
Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytesH E Broome, J C Reed, E P Godillot, et al.
The Journal of Experimental Medicine|September 1, 1995
Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansionX Zhang, L Giangreco, H E Broome, et al.
Immunology|March 1, 1995
Apoptosis and Bcl-2 expression in cultured murine splenic T cellsH E Broome, C M Dargan, E F Bessent, et al.
Bone Marrow Transplantation|September 4, 2003
FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasiaM L Tanner, C K Hoh, A Bashey, et al.
Pageof 2